(ALGS) Aligos Therapeutics - Performance -20% in 12m
ALGS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-80.02%
#132 in Peer-Group
Rel. Strength
21.69%
#6028 in Stock-Universe
Total Return 12m
-20.00%
#83 in Peer-Group
Total Return 5y
-97.78%
#168 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 45.62 USD |
| 52 Week Low | 3.99 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 78.49 |
| Buy/Sell Signal +-5 | 2.20 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ALGS (-20%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ALGS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALGS
| Total Return (including Dividends) | ALGS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 14.60% | 0.53% | 3.75% |
| 3 Months | 74.95% | 21.37% | 25.32% |
| 12 Months | -20.00% | -9.11% | 13.11% |
| 5 Years | -97.78% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | ALGS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.1% | -5.7% | 80.3% |
| 3 Months | 86.4% | 79.4% | 97.2% |
| 12 Months | -41.1% | -86.9% | 45.4% |
| 5 Years | -90.3% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th86.00 | 14.00% | 10.46% |
| 3 Month | %th83.00 | 44.14% | 39.60% |
| 12 Month | %th59.00 | -11.98% | -29.27% |
| 5 Years | %th17.00 | -96.85% | -98.84% |
FAQs
Does Aligos Therapeutics (ALGS) outperform the market?
No,
over the last 12 months ALGS made -20.00%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months ALGS made 74.95%, while XBI made 21.37%.
Performance Comparison ALGS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ALGS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 11.1% | 10.9% | -84.4% | -33% |
| US NASDAQ 100 | QQQ | 10.5% | 10.4% | -86% | -32% |
| German DAX 40 | DAX | 9.2% | 14.4% | -97.2% | -50% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10% | 10.9% | -88.1% | -42% |
| Hongkong Hang Seng | HSI | 11.5% | 11.6% | -104.9% | -59% |
| India NIFTY 50 | INDA | 11.8% | 13.8% | -85% | -19% |
| Brasil Bovespa | EWZ | 11.8% | 8.7% | -106.4% | -28% |
ALGS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 12.4% | 11.1% | -88.9% | -44% |
| Consumer Discretionary | XLY | 11.8% | 12.6% | -76.6% | -36% |
| Consumer Staples | XLP | 12.3% | 14.2% | -85% | -28% |
| Energy | XLE | 7.9% | 7.8% | -80.7% | -22% |
| Financial | XLF | 12.4% | 11.9% | -87% | -48% |
| Health Care | XLV | 12.8% | 13.5% | -75.5% | -15% |
| Industrial | XLI | 10.9% | 11.5% | -91.3% | -44% |
| Materials | XLB | 10.2% | 10.8% | -88% | -26% |
| Real Estate | XLRE | 12.2% | 14.8% | -83.3% | -32% |
| Technology | XLK | 9.4% | 7.4% | -88.5% | -30% |
| Utilities | XLU | 12.5% | 13.3% | -86.8% | -42% |
| Aerospace & Defense | XAR | 10.4% | 10.8% | -102.6% | -68% |
| Biotech | XBI | 9.5% | 14.1% | -70.3% | -11% |
| Homebuilder | XHB | 12.3% | 8.6% | -76.5% | -23% |
| Retail | XRT | 11% | 13.1% | -79.7% | -30% |
ALGS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.4% | 7.79% | -78.1% | -16% |
| Natural Gas | UNG | 13.4% | 25.1% | -65.2% | -14% |
| Gold | GLD | 12.6% | 15.4% | -102.3% | -59% |
| Silver | SLV | 9.8% | 14.9% | -100% | -38% |
| Copper | CPER | 4.5% | 4.5% | -104.8% | -38% |
ALGS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 13.9% | 13.5% | -80.7% | -17% |
| iShares High Yield Corp. Bond | HYG | 11.7% | 13.3% | -82.8% | -30% |